Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. (Q38446309)
Jump to navigation
Jump to search
scientific article published on July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. |
scientific article published on July 2013 |
Statements
Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study (English)
Bryan Dirks
Patrick F Deas
Aparna Raychaudhuri
Matthew R Dauphin
Robert A Lasser
Richard H Weisler